scispace - formally typeset
F

Fernanda M. Frank

Researcher at University of Buenos Aires

Publications -  43
Citations -  1333

Fernanda M. Frank is an academic researcher from University of Buenos Aires. The author has contributed to research in topics: Trypanosoma cruzi & Antigen. The author has an hindex of 22, co-authored 42 publications receiving 1214 citations. Previous affiliations of Fernanda M. Frank include National Scientific and Technical Research Council & National University of Cordoba.

Papers
More filters
Journal ArticleDOI

Trypanocidal and Leishmanicidal Activities of Sesquiterpene Lactones from Ambrosia tenuifolia Sprengel (Asteraceae)

TL;DR: The results shown herein suggest that psilostachyin and peruvin could be considered potential candidates for the development of new antiprotozoal agents against Chagas' disease and leishmaniasis.
Journal ArticleDOI

Oral Vaccination with Salmonella enterica as a Cruzipain-DNA Delivery System Confers Protective Immunity against Trypanosoma cruzi

TL;DR: It is indicated that Salmonella-mediated delivery of Cz-DNA by itself promotes the elicitation of an immune response that controls T. cruzi infection, thereby reducing parasite loads and subsequent damage to muscle tissues.
Journal ArticleDOI

Characterization of human infection by Leishmania spp. in the Northwest of Argentina: immune response, double infection with Trypanosoma cruzi and species of Leishmania involved.

TL;DR: Results indicate that the strong immune response against T. cruzi gave no protection to Leishmania, in spite of the serological cross-reaction between these parasites, and it is shown that more than 40% of the patients would be misdiagnosed as chagasic if complex antigens, as epimastigotes or soluble fraction from epimastsigotes, were used in IFA or ELISA.
Journal ArticleDOI

Trypanocidal and leishmanicidal activities of flavonoids from Argentine medicinal plants.

TL;DR: Hispidulin was more active than santin on promastigotes of Leishmania mexicana and no cytotoxic activity was observed on lymphoid cells, making hispidulin and s Santin potential lead compounds for the development of new natural drugs.
Journal ArticleDOI

Vaccination approaches against Trypanosoma cruzi infection

TL;DR: The recent advances in vaccine research and the development of the major antigen candidates, including cruzipain, trans-sialidase, amastigote surface protein, paraflagellar rod protein, among others are reviewed.